ArticleAmerican journal of respiratory and critical care medicine2019
Role of Glucosylceramide in Lung Endothelial Cell Fate and Emphysema.
Open access · greenAbstract read
In one paragraph
Article in American journal of respiratory and critical care medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 32 citations in OpenAlex.
- Ceramide-Driven Mechanisms in Pulmonary Fibrosis.Metabolites · 2026Review
- Investigating the exhaled lipid biomarkers among e-cigarette users compared to non-smokers.Lipids in health and disease · 2026Article
- Lipid metabolism-related genes regulate the immune microenvironment during ex vivo lung perfusion for lung transplants.Journal of thoracic disease · 2025Article
- Development of Genetically Encoded Fluorescent KSR1-Based Probes to Track Ceramides during Phagocytosis.International journal of molecular sciences · 2024Article
- Does Chronic Obstructive Pulmonary Disease Originate from Different Cell Types?American journal of respiratory cell and molecular biology · 2023Article
- Salvianolic acid B suppresses hepatic fibrosis by inhibiting ceramide glucosyltransferase in hepatic stellate cells.Acta pharmacologica Sinica · 2023Article
- Multiomics links global surfactant dysregulation with airflow obstruction and emphysema in COPD.ERJ open research · 2023Article
- Role of UDP-glucose ceramide glucosyltransferase in venous malformation.Frontiers in cell and developmental biology · 2023Article
- Article
- Cigarette smoke-induced airspace disease in mice develops independently of HIF-1α signaling in leukocytes.American journal of physiology. Lung cellular and molecular physiology · 2022Article
- Article
- Autophagy blockade synergistically enhances nanosonosensitizer-enabled sonodynamic cancer nanotherapeutics.Journal of nanobiotechnology · 2021Article
- Article
- Plasma Metabolomic Signatures of Chronic Obstructive Pulmonary Disease and the Impact of Genetic Variants on Phenotype-Driven Modules.Network and systems medicine · 2020Article
- Update in Chronic Obstructive Pulmonary Disease 2019.American journal of respiratory and critical care medicine · 2020Review
- IGSF3 mutation identified in patient with severe COPD alters cell function and motility.JCI insight · 2020Article
- MicroRNA-126-3p Inhibits Angiogenic Function of Human Lung Microvascular Endothelial Cells via LAT1 (L-Type Amino Acid Transporter 1)-Mediated mTOR (Mammalian Target of Rapamycin) Signaling.Arteriosclerosis, thrombosis, and vascular biology · 2020Article
- FSTL-1 Attenuation Causes Spontaneous Smoke-Resistant Pulmonary Emphysema.American journal of respiratory and critical care medicine · 2020Article
- Endothelial Cell Death in Emphysema: More Sugarcoating Needed?American journal of respiratory and critical care medicine · 2019Article
Corrections and comments
- Commented on by
Authors and funding
12 authors at 1 institution in 1 country.
Kengo KoikeDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, Colorado; and.ORCID 0000-0003-4677-3589
Evgeny V BerdyshevDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, Colorado; and.ORCID 0000-0002-1376-0098
Andrew M MikoszDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, Colorado; and.
Irina A BronovaDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, Colorado; and.
Anna S BronoffDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, Colorado; and.
John P JungDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, Colorado; and.
Erica L BeatmanDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, Colorado; and.
Kevin NiDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, Colorado; and.
Danting CaoDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, Colorado; and.ORCID 0000-0002-3850-2837
April K ScruggsDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, Colorado; and.ORCID 0000-0003-3943-4212
Karina A SerbanDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, Colorado; and.ORCID 0000-0002-9372-3034
Irina PetracheDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, Colorado; and.ORCID 0000-0003-1094-2600
National Jewish Health · US
Funding
Ceramide-induced Lung Destruction in EmphysemaR01HL077328 · NHLBI · NATIONAL JEWISH HEALTH · PI PETRACHE, IRINA · 2006 to 2024
$8.0MPREDOCTORAL TRAINING PROGRAM IN PHARMACOLOGYT32GM007635 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI DELL'ACQUA, MARK L · 1985 to 2023
$6.1MMetabolic profiles of COPD phenotypesP20HL113445 · NHLBI · NATIONAL JEWISH HEALTH · PI BOWLER, RUSSELL PAUL · 2012 to 2016
$4.7MMannose binding lectin-dependent complement activation in emphysemaK08HL141770 · NHLBI · NATIONAL JEWISH HEALTH · PI SERBAN, KARINA · 2019 to 2023
$793kSignaling Sphingolipids in COPDR03HL095440 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BERDYSHEV, EVGENY V, PETRACHE, IRINA · 2008 to 2009
$169kRole of TSG-6 mediated hyaluronic acid cross-linking in acute lung injuryF30HL136169 · NHLBI · NATIONAL JEWISH HEALTH · PI NI, KEVIN · 2018 to 2020
$129kNHLBI NIH HHS F30 HL136169NHLBI NIH HHS P20 HL113445NHLBI NIH HHS R01 HL077328NHLBI NIH HHS R03 HL095440NIGMS NIH HHS T32 GM007635
Abstract
PubMed holds no abstract for this paper.
Indexed as
AnimalsAutophagyCell Culture TechniquesCell DeathDisease Models, AnimalEndothelial CellsGlucosylceramidesMicePulmonary EmphysemaSmokingGlucosylceramidesapoptosisautophagychronic obstructive pulmonary diseaseendotheliumsphingolipids
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.